Recent progress and challenges in the treatment of spinal cord injury

Abstract

Spinal cord injury (SCI) disrupts the structural and functional connectivity between the higher center and the spinal cord, resulting in severe motor, sensory, and autonomic dysfunction with a variety of complications. The pathophysiology of SCI is complicated and multifaceted, and thus individual treatments acting on a specific aspect or process are inadequate to elicit neuronal regeneration and functional recovery after SCI. Combinatory strategies targeting multiple aspects of SCI pathology have achieved greater beneficial effects than individual therapy alone. Although many problems and challenges remain, the encouraging outcomes that have been achieved in preclinical models offer a promising foothold for the development of novel clinical strategies to treat SCI. In this review, we characterize the mechanisms underlying axon regeneration of adult neurons and summarize recent advances in facilitating functional recovery following SCI at both the acute and chronic stages. In addition, we analyze the current status, remaining problems, and realistic challenges towards clinical translation. Finally, we consider the future of SCI treatment and provide insights into how to narrow the translational gap that currently exists between preclinical studies and clinical practice. Going forward, clinical trials should emphasize multidisciplinary conversation and cooperation to identify optimal combinatorial approaches to maximize therapeutic benefit in humans with SCI.

Keywords

spinal cord injury / axon regeneration / functional recovery / therapeutic strategies / clinical translation

References

[1] Ajiboye AB, Willett FR, Young DR et al. Restoration of reaching and grasping movements through brain-controlled muscle stimulation in a person with tetraplegia: a proof-of-concept demonstration. Lancet 2017;389:1821–1830.

[2] Alizadeh A, Dyck SM, Karimi-Abdolrezaee S. Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms. Front Neurol 2019;10:282.

[3] Allahdadi KJ, de Santana TA, Santos GC et al. IGF-1 overexpression improves mesenchymal stem cell survival and promotes neurological recovery after spinal cord injury. Stem Cell Res Ther 2019;10:146.

[4] Álvarez Z, Kolberg-Edelbrock AN, Sasselli IR et al. Bioactive scaffolds with enhanced supramolecular motion promote recovery from spinal cord injury. Science 2021;374:848–856.

[5] Anderson KD, Guest JD, Dietrich WD et al. Safety of autologous human schwann cell transplantation in subacute thoracic spinal cord injury. J Neurotrauma 2017;34:2950–2963.

[6] Anderson MA, O’Shea TM, Burda JE et al. Required growth facilitators propel axon regeneration across complete spinal cord injury. Nature 2018;561:396–400.

[7] Andrabi SS, Yang J, Gao Y et al. Nanoparticles with antioxidant enzymes protect injured spinal cord from neuronal cell apoptosis by attenuating mitochondrial dysfunction. J Control Release 2020;317:300–311.

[8] Angeli CA, Edgerton VR, Gerasimenko YP et al. Altering spinal cord excitability enables voluntary movements after chronic complete paralysis in humans. Brain 2014;137:1394–1409.

[9] Angeli CA, Boakye M, Morton RA et al. Recovery of over-ground walking after chronic motor complete spinal cord injury. N Engl J Med 2018;379:1244–1250.

[10] Asboth L, Friedli L, Beauparlant J et al. Cortico-reticulo-spinal circuit reorganization enables functional recovery after severe spinal cord contusion. Nat Neurosci 2018;21:576–588.

[11] Asghari Adib E, Smithson LJ, Collins CA. An axonal stress response pathway: degenerative and regenerative signaling by DLK. Curr Opin Neurobiol 2018;53:110–119.

[12] Ashammakhi N, Kim HJ, Ehsanipour A et al. Regenerative therapies for spinal cord injury. Tissue Eng Part B Rev 2019;25:471–491.

[13] Assinck P, Duncan GJ, Hilton BJ et al. Cell transplantation therapy for spinal cord injury. Nat Neurosci 2017;20:637–647.

[14] Benavides FD, Jo HJ, Lundell H et al. Cortical and subcortical effects of transcutaneous spinal cord stimulation in humans with tetraplegia. J Neurosci 2020;40:2633–2643.

[15] Bilchak J, Yeakle K, Caron G et al. Enhancing KCC2 activity decreases hyperreflexia and spasticity after chronic spinal cord injury. Exp Neurol 2021;338:113605.

[16] Blackmore MG, Wang Z, Lerch JK et al. Kruppel-like Factor 7 engineered for transcriptional activation promotes axon regeneration in the adult corticospinal tract. Proc Natl Acad Sci USA 2012;109:7517–7522.

[17] Blanquie O, Bradke F. Cytoskeleton dynamics in axon regeneration. Curr Opin Neurobiol 2018;51:60–69.

[18] Bonizzato M, Pidpruzhnykova G, DiGiovanna J et al. Brain-controlled modulation of spinal circuits improves recovery from spinal cord injury. Nat Commun 2018;9:3015.

[19] Bouton CE, Shaikhouni A, Annetta NV et al. Restoring cortical control of functional movement in a human with quadriplegia. Nature 2016;533:247–250.

[20] Bradbury EJ, Burnside ER. Moving beyond the glial scar for spinal cord repair. Nat Commun 2019;10:3879.

[21] Bradley PM, Denecke CK, Aljovic A et al. Corticospinal circuit remodeling after central nervous system injury is dependent on neuronal activity. J Exp Med 2019;216:2503–2514.

[22] Burnside ER, Winter FD, Didangelos A et al. Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury. Brain 2018;141:2362–2381.

[23] Cao T, Chen H, Huang W et al. hUC-MSC-mediated recovery of subacute spinal cord injury through enhancing the pivotal subunits β3 and γ2 of the GABAA receptor. Theranostics 2022;12:3057–3078.

[24] Capogrosso M, Milekovic T, Borton D et al. A brain–spine interface alleviating gait deficits after spinal cord injury in primates. Nature 2016;539:284–288.

[25] Casha S, Zygun D, McGowan MD et al. Results of a phase II place-bo-controlled randomized trial of minocycline in acute spinal cord injury. Brain 2012;135:1224–1236.

[26] Ceto S, Sekiguchi KJ, Takashima Y, Nimmerjahn A, Tuszynski MH. 2020. Neural stem cell grafts form extensive synaptic networks that integrate with host circuits after spinal cord injury. Cell Stem Cell 27:430–440.e5.

[27] Chang K, Bian M, Xia X et al. Posttranslational modification of Sox11 regulates RGC survival and axon regeneration. eNeuro 2021;8:ENEURO.0358ENEURO.0358-0320.2020.

[28] Charsar BA, Brinton MA, Locke K et al. AAV2-BDNF promotes respiratory axon plasticity and recovery of diaphragm function following spinal cord injury. FASEB J 2019;33:13775–13793.

[29] Chen B, Li Y, Yu B et al. Reactivation of dormant relay pathways in injured spinal cord by KCC2 manipulations. Cell 2018a;174:521–535.e13.

[30] Chen X, Zhao Y, Li X et al. Functional multichannel poly(propylene fumarate)-collagen scaffold with collagen-binding neurotrophic factor 3 promotes neural regeneration after transected spinal cord injury. Adv Healthc Mater 2018b;7:1800315.

[31] Cheng L, Sami A, Ghosh B et al. LAR inhibitory peptide promotes recovery of diaphragm function and multiple forms of respiratory neural circuit plasticity after cervical spinal cord injury. Neurobiol Dis 2021;147:105153.

[32] Cho Y, Shin Jung E, Ewan Eric E et al. Activating injury-responsive genes with hypoxia enhances axon regeneration through neuronal HIF-1α. Neuron 2015;88:720–734.

[33] Crowley ST, Fukushima Y, Uchida S et al. Enhancement of motor function recovery after spinal cord injury in mice by delivery of brain-derived neurotrophic factor mRNA. Mol Ther Nucleic Acids 2019;17:465–476.

[34] Curt A, Hsieh J, Schubert M et al. The damaged spinal cord is a suitable target for stem cell transplantation. Neurorehabil Neural Repair 2020;34:758–768.

[35] Curtis E, Martin JR, Gabel B et al. 2018. A first-in-human, phase I study of neural stem cell transplantation for chronic spinal cord injury. Cell Stem Cell 22:941–950.e6.

[36] De Carvalho P, Goulardins JB, de Sousa DMN et al. Noninvasive neuromodulation techniques in difficult tracheostomy weaning of patients with spinal cord injury. Chest 2021;159:e299–e302.

[37] Deng J, Li M, Meng F et al. 3D spheroids of human placenta-derived mesenchymal stem cells attenuate spinal cord injury in mice. Cell Death Dis 2021;12:1096.

[38] Du K, Zheng S, Zhang Q et al. Pten deletion promotes regrowth of corticospinal tract axons 1 year after spinal cord injury. J Neurosci 2015;35:9754–9763.

[39] Dulin JN, Adler AF, Kumamaru H et al. Injured adult motor and sensory axons regenerate into appropriate organotypic domains of neural progenitor grafts. Nat Commun 2018;9:84.

[40] Dyck S, Kataria H, Alizadeh A et al. Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTPσ receptors promotes a beneficial inflammatory response following spinal cord injury. J Neuroinflamm 2018;15:90.

[41] Dyck S, Kataria H, Akbari-Kelachayeh K et al. LAR and PTPσ receptors are negative regulators of oligodendrogenesis and oligodendrocyte integrity in spinal cord injury. Glia 2019;67:125–145.

[42] Ehrmann C, Mahmoudi S, Prodinger B et al. Impact of spasticity on functioning in spinal cord injury: an application of graphical modelling. J Rehabil Med 2020;52:jrm00037.

[43] Fan L, Liu C, Chen X et al. Exosomes-loaded electroconductive hydrogel synergistically promotes tissue repair after spinal cord injury via immunoregulation and enhancement of myelinated axon growth. Adv Sci 2022;9:e2105586.

[44] Formento E, Minassian K, Wagner F et al. Electrical spinal cord stimulation must preserve proprioception to enable locomotion in humans with spinal cord injury. Nat Neurosci 2018;21:1728–1741.

[45] Friedli L, Rosenzweig ES, Barraud Q et al. Pronounced species divergence in corticospinal tract reorganization and functional recovery after lateralized spinal cord injury favors primates. Sci Transl Med 2015;7:302ra134.

[46] Gant KL, Guest JD, Palermo AE et al. Phase 1 safety trial of autologous human schwann cell transplantation in chronic spinal cord injury. J Neurotrauma 2022;39:285–299.

[47] Ganzer PD, Colachis SC, Schwemmer MA et al. Restoring the sense of touch using a sensorimotor demultiplexing neural interface. Cell 2020;181:763–773.e12.

[48] Gao Z, Zhang CJ, Xia N et al. Berberine-loaded M2 macrophage-derived exosomes for spinal cord injury therapy. Acta Biomater 2021;126:211–223.

[49] Geoffroy CG, Zheng B. Myelin-associated inhibitors in axonal growth after CNS injury. Curr Opin Neurobiol 2014;27:31–38.

[50] Gill ML, Grahn PJ, Calvert JS et al. Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia. Nat Med 2018;24:1677–1682.

[51] Goldshmit Y, Frisca F, Pinto AR et al. Fgf2 improves functional recovery-decreasing gliosis and increasing radial glia and neural progenitor cells after spinal cord injury. Brain Behav 2014;4:187–200.

[52] Grahn PJ, Lee KH, Kasasbeh A et al. Wireless control of intraspinal microstimulation in a rodent model of paralysis. J Neurosurg 2015;123:232–242.

[53] Greiner N, Barra B, Schiavone G et al. Recruitment of upper-limb motoneurons with epidural electrical stimulation of the cervical spinal cord. Nat Commun 2021;12:435.

[54] Griffin JM, Bradke F. Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem. EMBO Mol Med 2020;12:e11505.

[55] Gwak SJ, Macks C, Jeong DU et al. RhoA knockdown by cationic amphiphilic copolymer/siRhoA polyplexes enhances axonal regeneration in rat spinal cord injury model. Biomaterials 2017;121:155–166.

[56] Hall A, Lalli G. Rho and Ras GTPases in axon growth, guidance, and branching. Cold Spring Harb Perspect Biol 2010;2:a001818.

[57] Han Q, Ordaz JD, Liu NK et al. Descending motor circuitry required for NT-3 mediated locomotor recovery after spinal cord injury in mice. Nat Commun 2019;10:5815.

[58] Han Q, Xie Y, Ordaz JD et al. Restoring cellular energetics promotes axonal regeneration and functional recovery after spinal cord injury. Cell Metab 2020;31:623–641.e8.

[59] Hellal F, Hurtado A, Ruschel J et al. Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury. Science 2011;331:928–931.

[60] Hosseini SM, Alizadeh A, Shahsavani N et al. Suppressing CSPG/LAR/PTPσ axis facilitates neuronal replacement and synaptogenesis by human neural precursor grafts and improves recovery after spinal cord injury. J Neurosci 2022;42:3096–3121.

[61] Huang L, Li G, Ding Y et al. LINGO-1 deficiency promotes nerve regeneration through reduction of cell apoptosis, inflammation, and glial scar after spinal cord injury in mice. Exp Neurol 2019;320:112965.

[62] Huang N, Li S, Xie Y et al. Reprogramming an energetic AKT-PAK5 axis boosts axon energy supply and facilitates neuron survival and regeneration after injury and ischemia. Curr Biol 2021;31:3098–3114.e7.

[63] Hur EM, Saijilafu , Zhou FQ. Growing the growth cone: remodeling the cytoskeleton to promote axon regeneration. Trends Neurosci 2012;35:164–174.

[64] Hutson TH, Kathe C, Palmisano I et al. Cbp-dependent histone acetylation mediates axon regeneration induced by environmental enrichment in rodent spinal cord injury models. Sci Transl Med 2019;11:eaaw2064.

[65] Inanici F, Brighton LN, Samejima S et al. Transcutaneous spinal cord stimulation restores hand and arm function after spinal cord injury. IEEE Trans Neural Syst Rehabil Eng 2021;29:310–319.

[66] Ito S, Nagoshi N, Tsuji O et al. lotus inhibits neuronal apoptosis and promotes tract regeneration in contusive spinal cord injury model mice. eNeuro 2018;5:ENEURO.0303-0318.2018.

[67] Ito S, Nagoshi N, Kamata Y et al. LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury. Stem Cell Rep 2021;16:2703–2717.

[68] Jayaprakash N, Wang Z, Hoeynck B et al. Optogenetic interrogation of functional synapse formation by corticospinal tract axons in the injured spinal cord. J Neurosci 2016;36:5877–5890.

[69] Ji B, Li M, Wu WT et al. LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury. Mol Cell Neurosci 2006;33:311–320.

[70] Ji Z, Gao GB, Ma YM et al. Highly bioactive iridium metal-complex alleviates spinal cord injury via ROS scavenging and inflammation reduction. Biomaterials 2022;284:121481.

[71] Jin D, Liu Y, Sun F et al. Restoration of skilled locomotion by sprouting corticospinal axons induced by co-deletion of PTEN and SOCS3. Nat Commun 2015;6:8074.

[72] Kadoya K, Lu P, Nguyen K et al. Spinal cord reconstitution with homologous neural grafts enables robust corticospinal regeneration. Nat Med 2016;22:479–487.

[73] Kaila K, Price TJ, Payne JA et al. Cation-chloride cotransporters in neuronal development, plasticity and disease. Nat Rev Neurosci 2014;15:637–654.

[74] Kamata Y, Isoda M, Sanosaka T et al. A robust culture system to generate neural progenitors with gliogenic competence from clinically relevant induced pluripotent stem cells for treatment of spinal cord injury. Stem Cells Transl Med 2021;10:398–413.

[75] Karsy M, Hawryluk G. Modern medical management of spinal cord injury. Curr Neurol Neurosci Rep 2019;19:65.

[76] Keefe KM, Sheikh IS, Smith GM. Targeting neurotrophins to specific populations of neurons: NGF, BDNF, and NT-3 and their relevance for treatment of spinal cord injury. Int J Mol Sci 2017;18:548.

[77] Kim J, Mahapatra C, Hong JY et al. Functional recovery of contused spinal cord in rat with the injection of optimal-dosed cerium oxide nanoparticles. Adv Sci 2017;4:1700034.

[78] Kiyotake EA, Martin MD, Detamore MS. Regenerative rehabilitation with conductive biomaterials for spinal cord injury. Acta Biomater 2022;139:43–64.

[79] Ko S, Apple E, Liu Z et al. Age-dependent autophagy induction after injury promotes axon regeneration by limiting NOTCH. Autophagy 2020;16:2052–2068.

[80] Koda M, Hanaoka H, Fujii Y et al. Randomized trial of granulocyte colony-stimulating factor for spinal cord injury. Brain 2021;144:789–799.

[81] Koffler J, Zhu W, Qu X et al. Biomimetic 3D-printed scaffolds for spinal cord injury repair. Nat Med 2019;25:263–269.

[82] Kojima K, Miyoshi H, Nagoshi N et al. Selective ablation of tumorigenic cells following human induced pluripotent stem cell-derived neural stem/progenitor cell transplantation in spinal cord injury. Stem Cells Transl Med 2019;8:260–270.

[83] Kong G, Zhou L, Serger E et al. AMPK controls the axonal regenerative ability of dorsal root ganglia sensory neurons after spinal cord injury. Nat Metab 2020;2:918–933.

[84] Kramer AA, Olson GM, Chakraborty A et al. Promotion of corticospinal tract growth by KLF6 requires an injury stimulus and occurs within four weeks of treatment. Exp Neurol 2021;339:113644.

[85] Krishnan VS, Shin SS, Belegu V et al. Multimodal evaluation of TMS—induced somatosensory plasticity and behavioral recovery in rats with contusion spinal cord injury. Front Neurosci 2019;13:387.

[86] Kucher K, Johns D, Maier D et al. First-in-man intrathecal application of neurite growth-promoting anti-Nogo-A antibodies in acute spinal cord injury. Neurorehabil Neural Repair 2018;32:578–589.

[87] Kumamaru H, Lu P, Rosenzweig ES et al. Regenerating corticospinal axons innervate phenotypically appropriate neurons within neural stem cell grafts. Cell Rep 2019;26:2329–2339.e4.

[88] Lang C, Bradley PM, Jacobi A et al. STAT3 promotes corticospinal remodelling and functional recovery after spinal cord injury. EMBO Rep 2013;14:931–937.

[89] Lang BT, Cregg JM, DePaul MA et al. Modulation of the proteoglycan receptor PTPsigma promotes recovery after spinal cord injury. Nature 2015;518:404–408.

[90] Lebedev MA, Nicolelis MA. Brain–machine interfaces: from basic science to neuroprostheses and neurorehabilitation. Physiol Rev 2017;97:767–837.

[91] Leite SC, Pinto-Costa R, Sousa MM. Actin dynamics in the growth cone: a key player in axon regeneration. Curr Opin Neurobiol 2021;69:11–18.

[92] Lemon RN. Descending pathways in motor control. Annu Rev Neurosci 2008;31:195–218.

[93] Leszczynska K, Wincek A, Fortuna W et al. Treatment of patients with cervical and upper thoracic incomplete spinal cord injury using repetitive transcranial magnetic stimulation. Int J Artif Organs 2019;43:323–331.

[94] Li G, Che MT, Zeng X et al. Neurotrophin-3 released from implant of tissue-engineered fibroin scaffolds inhibits inflammation, enhances nerve fiber regeneration, and improves motor function in canine spinal cord injury. J Biomed Mater Res A 2018a;106:2158–2170.

[95] Li J, Wang Q, Wang H et al. Lentivirus mediating FGF13 enhances axon regeneration after spinal cord injury by stabilizing microtubule and improving mitochondrial function. J Neurotrauma 2018b;35:548–559.

[96] Li H, Kong R, Wan B et al. Initiation of PI3K/AKT pathway by IGF-1 decreases spinal cord injury-induced endothelial apoptosis and microvascular damage. Life Sci 2020;263:118572.

[97] Lipton Jonathan O, Sahin M. The neurology of mTOR. Neuron 2014;84:275–291.

[98] Liu SM, Xiao ZF, Li X et al. Vascular endothelial growth factor activates neural stem cells through epidermal growth factor receptor signal after spinal cord injury. CNS Neurosci Ther 2019a;25:375–385.

[99] Liu Z, Yang Y, He L et al. High-dose methylprednisolone for acute traumatic spinal cord injury: a meta-analysis. Neurology 2019b;93:e841–e850.

[100] Lowery LA, Vactor DV. The trip of the tip: understanding the growth cone machinery. Nat Rev Mol Cell Biol 2009;10:332–343.

[101] Lu P, Wang Y, Graham L et al. Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell 2012;150:1264–1273.

[102] Lu P, Woodruff G, Wang Y et al. Long-distance axonal growth from human induced pluripotent stem cells after spinal cord injury. Neuron 2014;83:789–796.

[103] Lutton C, Young YW, Williams R et al. Combined VEGF and PDGF treatment reduces secondary degeneration after spinal cord injury. J Neurotrauma 2012;29:957–970.

[104] Mao L, Gao W, Chen S et al. Epothilone B impairs functional recovery after spinal cord injury by increasing secretion of macrophage colony-stimulating factor. Cell Death Dis 2017;8:e3162.

[105] McPherson JG, Miller RR, Perlmutter SI. Targeted, activity-dependent spinal stimulation produces long-lasting motor recovery in chronic cervical spinal cord injury. Proc Natl Acad Sci USA 2015;112:12193–12198.

[106] Mercier LM, Gonzalez-Rothi EJ, Streeter KA et al. Intraspinal microstimulation and diaphragm activation after cervical spinal cord injury. J Neurophysiol 2017;117:767–776.

[107] Meyer Zu Reckendorf S, Moser D, Blechschmidt A et al. Motoneuron-specific PTEN deletion in mice induces neuronal hypertrophy and also regeneration after facial nerve injury. J Neurosci 2022;42:2474–2491.

[108] Nathan F, Ohtake Y, Wang S et al. Upregulating Lin28a promotes axon regeneration in adult mice with optic nerve and spinal cord injury. Mol Ther 2020;28:1902–1917.

[109] Ohtake Y, Sami A, Jiang X et al. Promoting axon regeneration in adult CNS by targeting liver kinase B1. Mol Ther 2019;27:102–117.

[110] Ong B, Wilson JR, Henzel MK. Management of the patient with chronic spinal cord injury. Med Clin N Am 2020;104:263–278.

[111] Oraee-Yazdani S, Akhlaghpasand M, Golmohammadi M et al. Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes. Stem Cell Res Ther 2021;12:445.

[112] Papa S, Vismara I, Mariani A et al. Mesenchymal stem cells encapsulated into biomimetic hydrogel scaffold gradually release CCL2 chemokine in situ preserving cytoarchitecture and promoting functional recovery in spinal cord injury. J Control Release 2018;278:49–56.

[113] Park H, Kim YM, Anh Hong LT et al. Dual-functional hydrogel system for spinal cord regeneration with sustained release of arylsulfatase B alleviates fibrotic microenvironment and promotes axonal regeneration. Biomaterials 2022;284:121526.

[114] Patel AK, Broyer RM, Lee CD et al. Inhibition of GCK-IV kinases dissociates cell death and axon regeneration in CNS neurons. Proc Natl Acad Sci USA 2020;117:33597–33607.

[115] Pikov V, McCreery DB, Han M. Intraspinal stimulation with a silicon-based 3D chronic microelectrode array for bladder voiding in cats. J Neural Eng 2020;17:065004.

[116] Potter-Baker K, Janini DP, Lin YL et al. Transcranial direct current stimulation (tDCS) paired with massed practice training to promote adaptive plasticity and motor recovery in chronic incomplete tetraplegia: a pilot study. J Spinal Cord Med 2017;41:503–517.

[117] Poulen G, Aloy E, Bringuier CM et al. Inhibiting microglia proliferation after spinal cord injury improves recovery in mice and nonhuman primates. Theranostics 2021;11:8640–8659.

[118] Puttagunta R, Tedeschi A, Sória MG et al. PCAF-dependent epigenetic changes promote axonal regeneration in the central nervous system. Nat Commun 2014;5:3527.

[119] Rosenzweig ES, Brock JH, Lu P et al. Restorative effects of human neural stem cell grafts on the primate spinal cord. Nat Med 2018;24:484–490.

[120] Rosenzweig ES, Salegio EA, Liang JJ et al. Chondroitinase improves anatomical and functional outcomes after primate spinal cord injury. Nat Neurosci 2019;22:1269–1275.

[121] Rowald A, Komi S, Demesmaeker R et al. Activity-dependent spinal cord neuromodulation rapidly restores trunk and leg motor functions after complete paralysis. Nat Med 2022;28:260–271.

[122] Rowland JW, Hawryluk GW, Kwon B et al. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 2008;25:E2.

[123] Sachdeva R, Nightingale TE, Pawar K et al. Noninvasive neuroprosthesis promotes cardiovascular recovery after spinal cord injury. Neurotherapeutics 2021;18:1244–1256.

[124] Saikia JM, Chavez-Martinez CL, Kim ND et al. A critical role for DLK and LZK in axonal repair in the mammalian spinal cord. J Neurosci 2022;42:3716–3732.

[125] Samejima S, Khorasani A, Ranganathan V et al. Brain–computer–spinal interface restores upper limb function after spinal cord injury. IEEE Trans Neural Syst Rehabil Eng 2021;29:1233–1242.

[126] Santamaria AJ, Benavides FD, Saraiva PM et al. Neurophysiological changes in the first year after cell transplantation in sub-acute complete paraplegia. Front Neurol 2021;11:514181.

[127] Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell 2017;168:960–976.

[128] Sayenko DG, Rath M, Ferguson AR et al. Self-assisted standing enabled by non-invasive spinal stimulation after spinal cord injury. J Neurotrauma 2019;36:1435–1450.

[129] Schaffran B, Bradke F. Reproducibility—the key towards clinical implementation of spinal cord injury treatments? Exp Neurol 2019;313:135–136.

[130] Schneider MP, Sartori AM, Ineichen BV et al. Anti-Nogo-A antibodies as a potential causal therapy for lower urinary tract dysfunction after spinal cord injury. J Neurosci 2019;39:4066–4076.

[131] Sharif H, Alexander H, Azam A et al. Dual motor cortex and spinal cord neuromodulation improves rehabilitation efficacy and restores skilled locomotor function in a rat cervical contusion injury model. Exp Neurol 2021;341:113715.

[132] Shen H, Xu B, Yang C et al. A DAMP-scavenging, IL-10-releasing hydrogel promotes neural regeneration and motor function recovery after spinal cord injury. Biomaterials 2022;280:121279.

[133] Silver DJ, Silver J. Contributions of chondroitin sulfate proteoglycans to neurodevelopment, injury, and cancer. Curr Opin Neurobiol 2014;27:171–178.

[134] Simeral JD, Hosman T, Saab J et al. Home use of a percutaneous wireless intracortical brain–computer interface by individuals with tetraplegia. IEEE Trans Biomed Eng 2021;68:2313–2325.

[135] Smith PD, Sun F, Park KK et al. SOCS3 deletion promotes optic nerve regeneration in vivo. Neuron 2009;64:617–623.

[136] Sofroniew MV. Dissecting spinal cord regeneration. Nature 2018;557:343–350.

[137] Stern S, Hilton BJ, Burnside ER et al. RhoA drives actin compaction to restrict axon regeneration and astrocyte reactivity after CNS injury. Neuron 2021;109:3436–3455.e9.

[138] Sun W, Larson MJ, Kiyoshi CM et al. Gabapentinoid treatment promotes corticospinal plasticity and regeneration following murine spinal cord injury. J Clin Invest 2020;130:345–358.

[139] Tedeschi A, Bradke F. Spatial and temporal arrangement of neuronal intrinsic and extrinsic mechanisms controlling axon regeneration. Curr Opin Neurobiol 2017;42:118–127.

[140] Tedeschi A, Dupraz S, Laskowski CJ et al. The calcium channel subunit Alpha2delta2 suppresses axon regeneration in the adult CNS. Neuron 2016;92:419–434.

[141] Tedeschi A, Dupraz S, Curcio M et al. ADF/Cofilin-mediated actin turnover promotes axon regeneration in the adult CNS. Neuron 2019;103:1073–1085.e6.

[142] Tolmacheva A, Savolainen S, Kirveskari E et al. Long-term paired associative stimulation enhances motor output of the tetraplegic hand. J Neurotrauma 2017;34:2668–2674.

[143] Urban MW, Ghosh B, Strojny LR et al. Cell-type specific expression of constitutively-active Rheb promotes regeneration of bulbospinal respiratory axons following cervical SCI. Exp Neurol 2018;303:108–119.

[144] Venkatesh I, Mehra V, Wang Z et al. Co-occupancy identifies transcription factor co-operation for axon growth. Nat Commun 2021;12:2555.

[145] Wagner FB, Mignardot JB, Le Goff-Mignardot CG et al. Targeted neurotechnology restores walking in humans with spinal cord injury. Nature 2018;563:65–71.

[146] Walter M, Lee AHX, Kavanagh A et al. Epidural spinal cord stimulation acutely modulates lower urinary tract and bowel function following spinal cord injury: a case report. Front Physiol 2018;9:1816.

[147] Wang X, Yigitkanli K, Kim CY et al. Human NgR-Fc decoy protein via lumbar intrathecal bolus administration enhances recovery from rat spinal cord contusion. J Neurotrauma 2014;31:1955–1966.

[148] Wang Z, Reynolds A, Kirry A et al. Overexpression of Sox11 promotes corticospinal tract regeneration after spinal injury while interfering with functional recovery. J Neurosci 2015;35:3139–3145.

[149] Wang X, Zhou T, Maynard GD et al. Nogo receptor decoy promotes recovery and corticospinal growth in non-human primate spinal cord injury. Brain 2020;143:1697–1713.

[150] Warner FM, Cragg JJ, Jutzeler CR et al. EMSCI Sites. Early administration of gabapentinoids improves motor recovery after human spinal cord injury. Cell Rep 2017;18:1614–1618.

[151] Warren PM, Steiger SC, Dick TE et al. Rapid and robust restoration of breathing long after spinal cord injury. Nat Commun 2018;9:4843.

[152] Watkins T, Wang B, Huntwork-Rodriguez S et al. DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury. Proc Natl Acad Sci USA 2013;110:4039–4044.

[153] Weng YL, An R, Cassin J et al. An intrinsic epigenetic barrier for functional axon regeneration. Neuron 2017;94:337–346.e6.

[154] Wenger N, Moraud EM, Raspopovic S et al. Closed-loop neuromodulation of spinal sensorimotor circuits controls refined locomotion after complete spinal cord injury. Sci Transl Med 2014;6:255ra133.

[155] Wertheim L, Edri R, Goldshmit Y et al. Regenerating the injured spinal cord at the chronic phase by engineered iPSCs-derived 3D neuronal networks. Adv Sci 2022;9:e2105694.

[156] West CR, Phillips AA, Squair JW et al. Association of epidural stimulation with cardiovascular function in an individual with spinal cord injury. JAMA Neurol 2018;75:630–632.

[157] Willett FR, Avansino DT, Hochberg LR et al. High-performance brain-to-text communication via handwriting. Nature 2021;593:249–254.

[158] Willyard C. How a revolutionary technique got people with spinal-cord injuries back on their feet. Nature 2019;572:20–25.

[159] Wincek A, Huber J, Leszczyńska K et al. The long-term effect of treatment using the transcranial magnetic stimulation rTMS in patients after incomplete cervical or thoracic spinal cord injury. J Clin Med 2021;10:2975.

[160] Wu D, Klaw MC, Connors T et al. Expressing constitutively active Rheb in adult neurons after a complete spinal cord injury enhances axonal regeneration beyond a chondroitinase-treated glial scar. J Neurosci 2015;35:11068–11080.

[161] Wu H, Ding L, Wang Y et al. MiR-615 regulates NSC differentiation in vitro and contributes to spinal cord injury repair by targeting LINGO-1. Mol Neurobiol 2020;57:3057–3074.

[162] Xu D, Wu D, Qin M et al. Efficient delivery of nerve growth factors to the central nervous system for neural regeneration. Adv Mater 2019;31:e1900727.

[163] Xu G, Xu S, Zhang YX et al. Cell-free extracts from human fat tissue with a hyaluronan-based hydrogel attenuate inflammation in a spinal cord injury model through M2 microglia/microphage polarization. Small 2022;18:2107838.

[164] Yang S, Chang MC. Transcranial direct current stimulation for the management of neuropathic pain: a narrative review. Pain Physician 2021;24:E771–E781.

[165] Yang Q, Ramamurthy A, Lall S et al. Independent replication of motor cortex and cervical spinal cord electrical stimulation to promote forelimb motor function after spinal cord injury in rats. Exp Neurol 2019;320:112962.

[166] Yao B, Christian KM, He C et al. Epigenetic mechanisms in neurogenesis. Nat Rev Neurosci 2016;17:537–549.

[167] Yao Y, Xu J, Yu T et al. Flufenamic acid inhibits secondary hemorrhage and BSCB disruption after spinal cord injury. Theranostics 2018;8:4181–4198.

[168] Ye J, Jin S, Cai W et al. Rationally designed, self-assembling, multi-functional hydrogel depot repairs severe spinal cord injury. Adv Healthc Mater 2021;10:e2100242.

[169] Yoshimura T, Kawano Y, Arimura N et al. GSK-3β regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 2005;120:137–149.

[170] Yu Q, Liao M, Sun C et al. LBO-EMSC hydrogel serves a dual function in spinal cord injury restoration via the PI3K-Akt-mTOR pathway. ACS Appl Mater Interfaces 2021;13:48365–48377.

[171] Zareen N, Dodson S, Armada K et al. Stimulation-dependent remodeling of the corticospinal tract requires reactivation of growth-promoting developmental signaling pathways. Exp Neurol 2018;307:133–144.

[172] Zhao C, Qin J, Li J et al. LINGO-1 regulates Wnt5a signaling during neural stem and progenitor cell differentiation by modulating miR-15b-3p levels. Stem Cell Res Ther 2021a;12:372.

[173] Zhao Y, Wang Q, Xie C et al. Peptide ligands targeting FGF receptors promote recovery from dorsal root crush injury via AKT/mTOR signaling. Theranostics 2021b;11:10125–10147.

[174] Zhou FQ, Snider WD. GSK-3β and microtubule assembly in axons. Science 2005;308:211–214.

[175] Zhou FQ, Zhou J, Dedhar S et al. NGF-induced axon growth is mediated by localized inactivation of GSK-3β and functions of the microtubule plus end binding protein APC. Neuron 2004;42:897–912.

[176] Zhou W, Silva M, Feng C et al. Exosomes derived from human placental mesenchymal stem cells enhanced the recovery of spinal cord injury by activating endogenous neurogenesis. Stem Cell Res Ther 2021;12:174.

RIGHTS & PERMISSIONS

2023 The Author(s) 2023. Published by Oxford University Press on behalf of Higher Education Press.